tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
DataSpaceR vs DoseFinding
A side-by-side editorial comparison of DataSpaceR and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
DataSpaceR vs DoseFinding: at a glance
What is DataSpaceR?
DataSpaceR's 1.0.0 rebuilt its query API and opened up HIV antibody sequence data.
The R client for the CAVD DataSpace reached 1.0.0 in July 2026 after five years of small fixes. The release removed the mAb grid filtering and view methods in favour of filtering an availableMabs object with data.table syntax, applied that pattern to every query method, and added a class for querying DAASH, the Database of Annotated Antibody Sequences for HIV-1. The August patch restored the LANL monoclonal-antibody metadata requests and batched BCR sequence queries.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
DataSpaceR vs DoseFinding: editorial side-by-side
DataSpaceR
2.5ANALYTICS
DataSpaceR's 1.0.0 rebuilt its query API and opened up HIV antibody sequence data.
◆ Current state
The R client for the CAVD DataSpace reached 1.0.0 in July 2026 after five years of small fixes. The release removed the mAb grid filtering and view methods in favour of filtering an availableMabs object with data.table syntax, applied that pattern to every query method, and added a class for querying DAASH, the Database of Annotated Antibody Sequences for HIV-1. The August patch restored the LANL monoclonal-antibody metadata requests and batched BCR sequence queries.
◆ Where it's heading
The package is converging on one query idiom — build a filtered object, then fetch — instead of per-domain grid methods, and each class now accepts multiple studies or antibodies rather than one. The 1.0.1 patch suggests the rewrite dropped functionality that users noticed, and it was put back rather than redesigned.
◆ Prediction
With DAASH access in place and the query surface unified, the next work is most likely more sequence-domain coverage and follow-up fixes to the batched query paths introduced in 1.0.1.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to DataSpaceR and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DataSpaceR or DoseFinding.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all DataSpaceR alternatives → · See all DoseFinding alternatives →
Recent activity from DataSpaceR and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 9d agoDataSpaceRLANL metadata requests restored and BCR queries batched
- 1mo agoDataSpaceRQuery API rebuilt and DAASH antibody sequence access added ⚡
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDataSpaceRFixes for antibody and donor queries
- 1y agoDataSpaceRLANL metadata added to neutralising-antibody pulls
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
- 4y agoDataSpaceRSession fix for CDS reports and snake-case bindings
Frequently asked questions
What is the difference between DataSpaceR and DoseFinding?
They serve adjacent needs but don't currently overlap on shipped themes. DataSpaceR is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DataSpaceR better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DataSpaceR is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DataSpaceR?
Top DataSpaceR alternatives in Analytics are ranked by recent ship velocity. Browse the "DataSpaceR alternatives" section above for the current picks, or visit /alternatives/dataspacer for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.